Análisis de la acción Gyrodyne LLC (GYRO)

Análisis de IA of Gyrodyne LLC (GYRO)

Mantener

Gyrodyne LLC (GYRO) is currently trading at $4.00, which is significantly below its 52-week high of $9.71, indicating potential for recovery. However, the stock has seen a year-to-date decline of 55.85% and a 20-day change of -15.07%, suggesting ongoing weakness. The RSI is extremely low at 8.117, indicating the stock is oversold, but this could also reflect deeper issues. The forward P/E ratio is 0, indicating no earnings expectations, which is a red flag. Given these factors, while there is potential upside, the significant risks outweigh the current buying opportunity, making it prudent to hold rather than buy.

Métricas de valoración

El PER previsto actual de Gyrodyne LLC (GYRO) es 0.00, frente a su media de 5 años de 0.00.

PER previsto

Muy infravalorado

Media 5A P/E

0.00

P/E actual

0.00

Sobrevalorada

0.00

Infravalorada

0.00

EV/EBITDA previsto

Muy infravalorado

Media 5A EV/EBITDA

0.00

EV/EBITDA actual

0.00

Sobrevalorada

0.00

Infravalorada

0.00

Precio/ventas previsto

Valor razonable

Media 5A P/S

0.12

P/S actual

0.00

Sobrevalorada

1.17

Infravalorada

-0.94

Escenarios de precio de Alphio AI para GYRO

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%GYRO

$9.32

Precio del escenario

B

Base

Base · 50%GYRO

$7.82

Precio del escenario

B

Bajista

Bajista · 25%GYRO

$6.16

Precio del escenario

Preguntas frecuentes sobre GYRO, respondidas por Alphio AI

Gyrodyne, LLC owns and manages diverse commercial properties. The Company’s primary business is the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) Counties, New York. The Company owns about a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York. In Cortlandt Manor, New York, the Company owns about 13.8 acres inclusive of the 31,421-square-foot Cortlandt Medical Center. It operates in the Real Estate sector (OPERATORS OF NONRESIDENTIAL BUILDINGS industry).

Gyrodyne LLC (GYRO) is currently trading at $4.00, which is significantly below its 52-week high of $9.71, indicating potential for recovery. However, the stock has seen a year-to-date decline of 55.85% and a 20-day change of -15.07%, suggesting ongoing weakness. The RSI is extremely low at 8.117, indicating the stock is oversold, but this could also reflect deeper issues. The forward P/E ratio is 0, indicating no earnings expectations, which is a red flag. Given these factors, while there is potential upside, the significant risks outweigh the current buying opportunity, making it prudent to hold rather than buy.